New 52 Week High Today

Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 3:59 PM EDT

164.05

+0.72 (+0.44%)

Volume

6,112,009

52 week range

62.55 - 165.14

Open160.00
Day High165.14
Day Low157.46
Prev Close163.33
52 Week High165.14
52 Week High Date05/23/24
52 Week Low62.55
52 Week Low Date11/02/23

Key Stats

Market Cap62.87B
Shares Out383.24M
10 Day Average Volume4.57M
Dividend-
Dividend Yield-
Beta1.55
YTD % Change64.89

KEY STATS

Open160.00
Day High165.14
Day Low157.46
Prev Close163.33
52 Week High165.14
52 Week High Date05/23/24
52 Week Low62.55
52 Week Low Date11/02/23
Market Cap62.87B
Shares Out383.24M
10 Day Average Volume4.57M
Dividend-
Dividend Yield-
Beta1.55
YTD % Change64.89

RATIOS/PROFITABILITY

EPS (TTM)-15.66
P/E (TTM)-10.48
Fwd P/E (NTM)-21.20
EBITDA (TTM)-4.559B
ROE (TTM)-37.68%
Revenue (TTM)5.153B
Gross Margin (TTM)22.43%
Net Margin (TTM)-115.82%
Debt To Equity (MRQ)4.49%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

The stock market gets nailed by the Fed, again. Plus, Starbucks' quiet comebackMay 22, 2024CNBC.com
Stocks making biggest moves midday: Target, Urban Outfitters, Tesla, ShopifyMay 22, 2024CNBC.com
Lightning Round: Hertz is too cheap right now, says Jim CramerMay 14, 2024CNBC.com
Cramer's Lightning Round: 'I'm a believer' in ModernaMay 14, 2024CNBC.com
Evercore ISI sees an end to 3 years of biotech underperformance, gives 5 top stocksMay 14, 2024CNBC.com

Content From Our Affiliates

SPY ETF Update, 5/23/2024  11 Hours AgoTipRanks
QQQ ETF Update, 5/22/2024May 22, 2024TipRanks
Moderna wins European patent case in Pfizer, BioNTech dispute, FT reportsMay 17, 2024TipRanks
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), Moderna (MRNA)May 16, 2024TipRanks
Early notable gainers among liquid option names on May 13thMay 13, 2024TipRanks

Profile

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

Jerh Collins

Chief Technical Operations and Quality Officer

James Mock

Chief Financial Officer

Brad Miller

Chief Information Officer

Address

325 BINNEY STREET

Cambridge, MA

02142

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ILMN Illumina Inc	105.85	-1.54	-1.43%
BIIB Biogen Inc	218.06	-7.15	-3.17%
BNTX Biontech SE	99.00	-3.30	-3.23%
GMAB Genmab A/S	29.34	-0.47	-1.58%
CRL Charles River Laboratories International Inc	217.55	-1.45	-0.66%